Adler LA, Dirks B, Deas PF, Raychaudhuri A, Dauphin MR, Lasser RA, Weisler RH (2013) Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 74:694–702. https://doi.org/10.4088/JCP.12m08144

Article  CAS  PubMed  Google Scholar 

Alwindi M, Bizanti A (2023) Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions. Heliyon 9:e22413. https://doi.org/10.1016/j.heliyon.2023.e22413

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barlow RB, Johnson O (1989) Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds. Br J Pharmacol 98:799–808. https://doi.org/10.1111/j.1476-5381.1989.tb14608.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barragán E, Breuer D, Döpfner M (2017) Efficacy and safety of Omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD. J Atten Disord 21:433–441. https://doi.org/10.1177/1087054713518239

Article  PubMed  Google Scholar 

Biederman J, Fried R, Hammerness P, Surman C, Mehler B, Petty CR, Faraone SV, Miller C, Bourgeois M, Meller B, Godfrey KM, Reimer B (2012) The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J Psychiatr Res 46:484–491. https://doi.org/10.1016/j.jpsychires.2012.01.007

Article  PubMed  Google Scholar 

Blick SKA, Keating GM (2007) Lisdexamfetamine. Paediatr Drugs 9:129–135 discussion 136. https://doi.org/10.2165/00148581-200709020-00007

Article  PubMed  Google Scholar 

Blum K, Chen ALC, Braverman ER, Comings DE, Chen TJH, Arcuri V, Blum SH, Downs BW, Waite RL, Notaro A, Lubar J, Williams L, Prihoda TJ, Palomo T, Oscar-Berman M (2008) Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 4:893–918. https://doi.org/10.2147/ndt.s2627

Article  PubMed  PubMed Central  Google Scholar 

Bristot G, Ascoli BM, Scotton E, Géa LP, Pfaffenseller B, Kauer-Sant’Anna M (2019) Effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania. Braz J Psychiatry 41:419–427. https://doi.org/10.1590/1516-4446-2017-0001

Article  PubMed  PubMed Central  Google Scholar 

Burns C, Kidron A (eds) (2022) Biochemistry, tyramine. StatPearls. Internet. In: StatPearls Publishing, Treasure Island (FL), p 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK563197/

Comiran E, Kessler FH, Fröehlich PE, Limberger RP (2016) Lisdexamfetamine: a pharmacokinetic review. Eur J Pharm Sci 89:172–179. https://doi.org/10.1016/j.ejps.2016.04.026

Article  CAS  PubMed  Google Scholar 

Crooks PA, Zheng G, Vartak AP, Culver JP, Zheng F, Horton DB, Dwoskin LP (2011) Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse. Curr Top Med Chem 11:1103–1127. https://doi.org/10.2174/156802611795371332

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhillon S, Yang LPH, Curran MP (2008) Bupropion: a review of its use in the management of major depressive disorder. Drugs 68:653–689. https://doi.org/10.2165/00003495-200868050-00011

Article  CAS  PubMed  Google Scholar 

Di Miceli M, Derf A, Gronier B (2022) Consequences of acute or chronic methylphenidate exposure using ex vivo neurochemistry and in vivo electrophysiology in the prefrontal cortex and striatum of rats. Int J Mol Sci 23:8588. https://doi.org/10.3390/ijms23158588

Article  CAS  PubMed  PubMed Central  Google Scholar 

DuPaul GJ, Weyandt LL, Rossi JS, Vilardo BA, O’Dell SM, Carson KM, Verdi G, Swentosky A (2012) Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD. J Atten Disord 16:202–220. https://doi.org/10.1177/1087054711427299

Article  PubMed  Google Scholar 

Duvall MG, Levy BD (2016) DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 785:144–155. https://doi.org/10.1016/j.ejphar.2015.11.001

Article  CAS  PubMed  Google Scholar 

Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 1216:86–98. https://doi.org/10.1111/j.1749-6632.2010.05906.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

FDA (2017) Mydayis. https://pi.shirecontent.com/PI/PDFs/Mydayis_USA_ENG.pdf

FDA (2009) Ritalin. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010187s077lbl.pdf

Foley KF, DeSanty KP, Kast RE (2006) Bupropion: Pharmacology and therapeutic applications. Expert Rev Neurother 6:1249–1265. https://doi.org/10.1586/14737175.6.9.1249

Article  CAS  PubMed  Google Scholar 

Freyberg Z, Sonders MS, Aguilar JI, Hiranita T, Karam CS, Flores J, Pizzo AB, Zhang Y, Farino ZJ, Chen A, Martin CA, Kopajtic TA, Fei H, Hu G, Lin YY, Mosharov EV, McCabe BD, Freyberg R, Wimalasena K, Hsin LW, Sames D, Krantz DE, Katz JL, Sulzer D, Javitch JA (2016) Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nat Commun 7:10652. https://doi.org/10.1038/ncomms10652

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garey JD, Lusskin SI, Scialli AR (2020) Teratogen update: amphetamines. Birth Defects Res 112:1171–1182. https://doi.org/10.1002/bdr2.1774

Article  CAS  PubMed  Google Scholar 

Guillot TS, Miller GW (2009) Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Mol Neurobiol 39:149–170. https://doi.org/10.1007/s12035-009-8059-y

Article  CAS  PubMed  Google Scholar 

Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ, Zachrisson O, Mercer A, Miller GW (2008) PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides 42:423–434. https://doi.org/10.1016/j.npep.2008.04.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hauser J, Makulska-Gertruda E, Reissmann A, Sontag TA, Tucha O, Lange KW (2014) The effects of nutritional polyunsaturated fatty acids on locomotor activity in spontaneously hypertensive rats. Atten Defic Hyperact Disord 6:61–65. https://doi.org/10.1007/s12402-013-0125-7

Article  PubMed  Google Scholar 

Healy-Stoffel M, Levant B (2018) N-3 (Omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets 17:216–232. https://doi.org/10.2174/1871527317666180412153612

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heinzerling KG, Swanson AN, Hall TM, Yi Y, Wu Y, Shoptaw SJ (2014) Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. Addiction 109:1878–1886. https://doi.org/10.1111/add.12636

Article  PubMed  PubMed Central  Google Scholar 

Hesse LM, Venkatakrishnan K, Court MH, von Moltke LL, Duan SX, Shader RI, Greenblatt DJ (2000) CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos 28:1176–1183

CAS  PubMed  Google Scholar 

Huss M, Duhan P, Gandhi P, Chen CW, Spannhuth C, Kumar V (2017) Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity. Neuropsychiatr Dis Treat 13:1741–1751. https://doi.org/10.2147/NDT.S130444

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hutson PH, Pennick M, Secker R (2014) Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. Neuropharmacology 87:41–50.